Time filter

Source Type

Monterrey, Mexico

The University of Monterrey is a private Roman Catholic institution of higher learning located in Monterrey, Mexico.UDEM was founded by the Daughters of the Immaculate Mary of Guadalupe, the nuns of the Sacred Heart, the Marist Brothers and the La Salle members, supported by an association of Catholic citizens. The idea originated from a recommendation given by the Second Vatican Council to use educational activities in favor of teaching the principles of the catholic doctrine.The founding religious groups already had a deep history in Monterrey. The Society of the Sacred Heart of Jesus had been working in Monterrey since 1908, and the Sisters of Immaculate Mary of Guadalupe founded Labastida University in 1951, and had been running Labastida College since 1919, an institution devoted to the education of girls and young ladies.On the other hand, the Marist Brothers had been working in Monterrey since 1905, and La Salle Brothers, who had left Mexico during the Revolution war, returned in 1942 to Monterrey to found the Instituto Regiomontano.On July 8, 1969, the university was recognized as such by the state of Nuevo Leon and on September 8 of the same year it began operating as an educational institution housed in 5 different facilities owned by the very same groups and associations that funded it, such as Labastida school.Currently, UDEM educates over 12 thousand students, including high school students, undergraduates and postgraduates. The school offers 4 high school modes, 35 majors, 15 baccalaureate degrees and 29 medical specialties and doctorates.UDEM offers a number of choices to study abroad; UDEM has established bilateral, reciprocal and unilateral agreements, as well as arrangements through academic exchange agencies.In 2002, UDEM signed 26 new bilateral agreements with universities in the United States – such as the University of California – Berkeley and other universities in Spain, Italy, Belgium, England , Germany and France . Wikipedia.

De la Rosa M.,University of Monterrey
The International journal of oral & maxillofacial implants

The aim of this retrospective study was to evaluate the predictors of peri-implant bone loss in a sample of patients treated with 10-mm implants and single crowns who underwent periodontal/peri-implant maintenance (PM) in a Mexican private periodontal practice. Outcomes of a group of systemically healthy, partially edentulous patients attended up to July 2012 were assessed. Patient data were considered for inclusion if they involved treatment of partially edentulous sites with 10-mm-long implants and single crown restorations, as well as at least 3 years of regular PM following implant placement. Peri-implant bone loss was evaluated from data recorded at the most recent examination. Logistic regression analysis was performed to investigate associations between peri-implant bone loss and sex, duration of PM, location and number of implants placed per patient, region of the mouth, smoking status, type of implant, and retention of restoration. A sample of 104 subjects who had been treated with four different types of dental implants and maintained for at least 3 years was selected. Of the 148 implants placed and followed for an average period of continuing PM of 6 years (range, 3 to 15 years), only one implant (1.8%) was lost. The outcomes of logistic regression analysis showed that the independent variables smoking, retention of restoration (cemented vs screw-retained), and type of implant (internal- or external-hex) were found to be correlated with peri-implant bone loss, with odds ratios of 39.64, 4.85, and 0.04, respectively. Peri-implant bone loss was significantly associated with smoking status, the type of implant (ie, externally hexed), and type of retention (ie, cemented). Overall, all patients maintained low rates of bone loss. Source

Murray S.B.,University of Sydney | Rieger E.,Australian National University | Touyz S.W.,University of Sydney | Garcia Y.D.L.G.,University of Monterrey
International Journal of Eating Disorders

Objective: Muscle dysmorphia is a relatively recently identified psychological condition that, since its inception, has been variously conceptualized as an eating disorder and subsequently as a type of body dysmorphic disorder within the somatoform disorders. This review aims to inform and encourage ongoing debate surrounding the diagnostic placement of this disorder. Method: We present a review and synthesis of the extant literature with a view to informing future decisions regarding the conceptualization of muscle dysmorphia. Results: The validity of muscle dysmorphia as a clinical entity has been empirically demonstrated. While the condition bears little semblance to somatization as currently conceptualized, the research suggests a strong conceptual similarity with anorexia nervosa. However, future research needs to utilize more appropriate measures of male eating disorder pathology. Muscle dysmorphia is also inclusive of obsessive compulsive features that are typical to those seen in eating disorder presentations. Discussion: We suggest that muscle dysmorphia be reanalyzed through the lens of an eating disorder spectrum. Recognition of muscle dysmorphia as an eating disorder may offer more clinical utility in recognizing the male experience of eating disorder pathology and also help reduce the number of current male cases falling into the EDNOS category. © 2010 by Wiley Periodicals, Inc. Source

Russell-Jones D.,University of Surrey | Cuddihy R.M.,International Diabetes Center | Hanefeld M.,TU Dresden | Kumar A.,Diabetes Care and Research Center | And 4 more authors.
Diabetes Care

OBJECTIVE - To test the safety and efficacy of exenatide once weekly (EQW) compared with metformin (MET), pioglitazone (PIO), and sitagliptin (SITA) over 26 weeks, in suboptimally treated (diet and exercise) drug-naive patients with type 2 diabetes. RESEARCH DESIGN AND METHODS - Patients were randomized to subcutaneous (SC) EQW 2.0 mg + oral placebo (n = 248), MET 2,000 mg/day + SC placebo (n = 246), PIO45 mg/day + SC placebo (n = 163), or SITA 100 mg/day + SC placebo (n = 163) for 26 weeks. MET and PIO therapies were increased to maximum-tolerated dosages. Injections with EQW or placebo were administered weekly, while oral medication or placebo was administered daily. RESULTS - Baseline characteristics were as follows: 59% men, 67% Caucasian, mean age 54 years, HbA1c 8.5%, fasting serum glucose 9.9 mmol/L, body weight 87.0 kg, and diabetes duration 2.7 years. HbA 1c reductions (%) at 26 weeks (least-squares means) with EQW versus MET, PIO, and SITA were -1.53 vs. -1.48 (P = 0.620), -1.63 (P = 0.328), and -1.15 (P < 0.001), respectively. Weight changes (kg) were -2.0 vs. -2.0 (P = 0.892), +1.5 (P < 0.001), and -0.8 (P < 0.001), respectively. Common adverse events were as follows: EQW, nausea (11.3%) and diarrhea (10.9%); MET, diarrhea (12.6%) and headache (12.2%); PIO, nasopharyngitis (8.6%) and headache (8.0%); and SIT, nasopharyngitis (9.8%) and headache (9.2%). Minor (confirmed) hypoglycemia was rarely reported. No major hypoglycemia occurred. CONCLUSIONS - EQW was noninferior to MET but not PIO and superior to SITA with regard to HbA1c reduction at 26 weeks. Of the agents studied, EQW and MET provided similar improvements in glycemic control along with the benefit of weight reduction and no increased risk of hypoglycemia. © 2012 by the American Diabetes Association. Source

Alo K.M.,Texas Medical Center Houston | Alo K.M.,University of Monterrey | Abramova M.V.,Health Science Center | Richter E.O.,Health Science Center
Progress in Neurological Surgery

Since its inception in the 1970s, peripheral neuromodulation has become an increasingly common procedure to treat chronic neuropathic disorders. Historically, peripheral nerve stimulation (PNS) originated with the placement of large surface cuff electrodes, which was refined by the introduction of functional nerve mapping with circumferential electrical stimulation. This substantially improved the targeting of sensory fascicles. Surgical placement of spinal cord stimulation (SCS) 'button type' paddle electrodes was replaced when the introduction of percutaneous cylindrical SCS electrodes expanded the spectrum of PNS applications and improved the ability to target afferent sensory fibers as well as reducing the complication rate. To further refine functional mapping for the placement of these percutaneous electrodes, radiofrequency needle probes have more recently been employed to elicit paresthesias in awake patients to map the pain generators and guide treatment. In this chapter, we provide a description of the development and basic mechanisms of peripheral nerve stimulation, as well as a more detailed description of the two most commonly employed forms of peripheral nerve stimulation: occipital nerve stimulation for occipital neuralgia, and subcutaneous peripheral nerve field stimulation to stimulate free nerve endings within the subcutaneous tissue when the pain is limited to a small, well-localized area. The closely related ideas of internal and external targeted subcutaneous stimulation are also discussed. Copyright © 2011 S. Karger AG, Basel. Source

Ramon-Fox F.G.,Technological Institute of Nuevo Leon | Sada P.V.,University of Monterrey
Revista Mexicana de Astronomia y Astrofisica

Four transits of the exoplanet HAT-P-23b were recently observed with the 0.36 m telescope at the Universidad de Monterrey Observatory. The four light curves were successfully combined to obtain a resulting one with reduced scat- tering per bin. This curve was modeled using a Monte Carlo method to obtain the essential parameters that characterize the system. Assuming orbital param- eters such as eccentricity e and longitude of periastron ω from the discovery pa- per, we found values of Rp/R* = 0.1105+0.0015 -0.0013 for the planet-to-star radius ratio, a/R* = 4.23+0.06 -0.12 for the scaled semimajor axis, and an orbital inclination of the system of i = 87.9°+1.5 -2.2. We also derive an improved orbital period of 1.2128868 ± 0.0000004 days (To = 2, 454, 852.26542 ± 0.00018 BJD TDB) for the system. © Copyright 2013: Instituto de Astronomía, Universidad Nacional Autónoma de México. Source

Discover hidden collaborations